Company Filing History:
2 out of 915 
2 out of 1,289 
Years Active: 2022-2024
Title: Fabian Coscia: Innovator in Cancer Treatment
Introduction
Fabian Coscia is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of cancer treatment, particularly through his innovative approaches targeting specific antigens in ovarian cancer. With a total of 2 patents, his work is paving the way for new therapeutic methods.
Latest Patents
Coscia's latest patents focus on methods of treating cancers with CT45 targeted therapies. The current disclosure relates to methods for treating ovarian cancer based on specific antigen expression of the cancer. Furthermore, the expressed antigen may be used in immunotherapeutic methods for the treatment of ovarian cancer. Aspects of the disclosure relate to immunotherapies targeting CT45 polypeptides, methods for treating ovarian cancer based on CT45 expression, and kits for detecting CT45 polypeptides and nucleotides.
Career Highlights
Throughout his career, Coscia has worked with esteemed institutions such as the University of Chicago and the Max Planck Society for the Advancement of Science. His research has been instrumental in advancing the understanding and treatment of cancer.
Collaborations
Some of his notable coworkers include Ernst Lengyel and Matthias Mann. Their collaborative efforts have contributed to the success of his research and innovations.
Conclusion
Fabian Coscia's work in cancer treatment exemplifies the impact of innovative thinking in medicine. His patents and collaborations highlight the importance of targeted therapies in improving patient outcomes.